Lipid-lowering drugs (statins), cholesterol, and coenzyme Q10. The Baycol case – a modern Pandora’s box
- 28 February 2002
- journal article
- editorial
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 56 (1) , 56-59
- https://doi.org/10.1016/s0753-3322(01)00150-0
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Pleiotropic effects of statins and their clinical significanceThe American Journal of Cardiology, 2001
- Statins and cancer: a case of meta-uncertaintyThe American Journal of Medicine, 2001
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Lotronex and the FDA: a fatal erosion of integrityThe Lancet, 2001
- Physicians and the Pharmaceutical IndustryJAMA, 2000
- Low-density lipoprotein-independent effects of statinsCurrent Opinion in Lipidology, 1999